Kurylovich K.A., Komissarov K.S., Krasko O.V., Kamisarau S.I., Ilyinchyk А.V., Prylutski S.V., Zhaholkin Y.Y.
Personalization of renal replacement therapy and its effect on survival of patients with stage 5 chronic kidney disease aged 60 and older
|
№4 / 2024
|
Kurylovich K.A., Komissarov K.S., Krasko O.V.
Prognostic value of the Charlson comorbidity index i n patients aged 60 years and older starting chronic dialysis treatment
|
№1 / 2024
|
Kurilovich K.A., Komissarov K.S., Krasko O.V.
Chronic dialysis in elderly and senile patients: survival and factors affecting outcome. Single-center experience
|
№1 / 2023
|
Rind A.R., Essaian A.M., Zaraiski M.I.
miRNAs and indicators of mineral metabolism in the population of dialysis patients
|
№1 / 2022
|
A.M. Esayan, A.R. Rind
The role of patient’s adherence in the treatment of hyperphosphatemia in chronic kidney disease
|
№2 / 2020
|
G.V. Volgina, N.A. Mikhailovа
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy
|
№2 / 2020
|
O.S. Arisheva, A.S. Larchenko, A.I. Ushakova, O.N. Kotenko
Direct-acting antiviral agents in the treatment of chronic hepatitis C in dialysis patients
|
№3 / 2017
|
O.V. Semeshina, V.N. Luchaninova, N.L. Kozlovskaja, N.V. Gorelik, E.A. Mel'nikova, T.P. Mankevich, V.N. Stepanjuk, A.A. Grivachevskaja, H.M. Emirova, G.A. Generalova, E.M. Ibragimova
"Autoimmune" atypical hemolytic-uremic syndrome in a child - genetic carrier of multiple polymorphisms of hemostasis genes (clinical observation)
|
№4 / 2015
|
Т.Yu. Zhirnova, Е.Е. Аchkasov, O.M. Tsirulnikova, E.М. Shilov, S.D. Runenko
Evaluation of functional state and adaptive body reserves in recipients with donor kidney
|
№4 / 2014
|
I.L. Novoseltsev, N.L. Novoseltseva, E.A. Kuznetsova, Yu.V. Mihailova
Experience of darbeporetin alfa use in management of anaemia in patients with chronic renal insufficiency
|
№2 / 2012
|